Both in Pharmaceuticals
BioAge Labs vs Fulcrum Therapeutics
Over the past year BIOA returned −20.9% and FULC returned −58.9%; their daily moves had a correlation of 0.13.
BIOA −20.9% FULC −58.9%Growth of $1, one year, split-adjusted
| Metric | BIOA | FULC |
|---|---|---|
| Price | $5.87 | $3.71 |
| Market cap | $269.4M | $283.4M |
| Today | −1.18% | −1.59% |
| 1 month | −13.8% | +0.8% |
| 6 months | −65.0% | −49.6% |
| Year to date | −55.6% | −67.2% |
| 1 year | −23.6% | −60.4% |
| Revenue growth (YoY) | +1.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −1064.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 26.0× | — |
| Net cash | $318.7M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 17.2% |
| Short % of float | 12.0% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).